- Course Description
- Course Credits
Expiring Soon: October 13, 2024
UHMS 2021 Virtual Annual Scientific Meeting Day 1
(As presented June 10, 2021)
Overall Goal of the UHMS Annual Scientific Meeting
The UHMS Annual Scientific Meeting's primary goal is to provide a forum for professional scientific growth and development of the participants to improve knowledge and competence in order to further patient outcomes. The meeting provides a basis for exchange of ideas, both scientific and practical, among physicians, researchers, and other health care professionals. The UHMS Annual Scientific Meeting consists of abstract and poster presentations, plenary sessions, the annual Kindwall and Lambertsen lectures.
Estimated time to complete this activity: 6.5 hours
Termination Date: October 13, 2024 or sooner if material becomes out of date after annual reviews.
Pricing
- UHMS Regular Member: $113.75
- UHMS Associate Member: $81.26
- Non-Member: $146.25
THURSDAY, JUNE 10
|
Plenary: Likely Mechanisms for Hyperbaric Oxygen in the Management of COVID-19 Patients |
John Feldmeier, DO |
|
Plenary: HBO2 in treating Covid 19 respiratory distress Panel |
Scott Gorenstein, MD, David Lee, MD, and Sandra Wainwright, MD |
|
A1: Glymphatic dysfunction and neuroinflammation as manifestations of CNS decompression sickness. |
Stephen R. Thom, MD |
|
A2: Neural proteins and auto-antibodies after carbon monoxide poisoning |
Lindell Weaver. MD |
|
A3: The Effect of Total Compression Time and Rate (Slope) of Compression on the Incidence of Symptomatic Eustachian Tube Dysfunction and Middle Ear Barotrauma: A Phase II Prospective Study |
Owen J. O’Neill, MD |
|
Plenary: Central Retinal Artery Occlusion |
Brian Mac Grory, MD |
|
Kindwall Keynote: Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial: A Multicenter Phase II Adaptive Clinical Trial Funded by the NINDS |
Gaylan Rockswold, MD |
|
B1: Effect of hyperbaric oxygen therapy on Xerostomia and taste in patients who have undergone head and neck radiation therapy |
Marvin Heyboer, MD |
|
B2: Evidence-supported HBO2 therapy in femoral head necrosis: A systematic review and meta-analysis. |
Vincenzo Zanon, MD |
|
B3: Diabetic foot wound case analysis: Amputations and cost of care with and without hyperbaric oxygen |
Kayla Deru |
|
B7: Retrospective case-control study of long-term health outcomes after carbon monoxide poisoning |
Lindell Weaver, MD |
|
Plenary: Registry Panel to include International registries |
Michael Bennett, MD, Jay Buckey, MD, and Caroline Fife, MD |
CONTINUING EDUCATION (If you attended this meeting via live stream on June 10th, you will not be eligible for continuing education credit again):
Designation Statements:
- Physician CME: The Undersea and Hyperbaric Medical Society designates this enduring material for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nursing CEU: Approved license types: Advanced Registered Nurse Practitioner; Clinical Nurse Specialist; Licensed Practical Nurse; Registered Nurse; Certified Nursing Assistant; Respiratory Care Practitioner Critical Care; Respiratory Care Practitioner Non-Critical Care; Registered Respiratory Therapist; Certified Respiratory Therapist. This enduring material is approved for 6.5 contact hours by the Florida Board of Registered Nursing Provider #50-10881.
- NBDHMT: Content for this day is not within the scope designated by NBDHMT for Category ‘a’ credit. NBDHMT Credit offerings are available for Day 2 and Day 3 through NBHDMT.
Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society.
Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with ineligible companies. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.
No individuals in control of content (planners/faculty/reviewers/authors) for this educational activity have relevant financial relationship(s) to disclose with ineligible companies, whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
No commercial support was received for this activity.
| 6.5 | |
| 6.5 |